Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18328118rdf:typepubmed:Citationlld:pubmed
pubmed-article:18328118lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:18328118lifeskim:mentionsumls-concept:C0034380lld:lifeskim
pubmed-article:18328118lifeskim:mentionsumls-concept:C0022661lld:lifeskim
pubmed-article:18328118lifeskim:mentionsumls-concept:C0403447lld:lifeskim
pubmed-article:18328118lifeskim:mentionsumls-concept:C0019046lld:lifeskim
pubmed-article:18328118lifeskim:mentionsumls-concept:C0011945lld:lifeskim
pubmed-article:18328118lifeskim:mentionsumls-concept:C0004083lld:lifeskim
pubmed-article:18328118lifeskim:mentionsumls-concept:C0937950lld:lifeskim
pubmed-article:18328118pubmed:issue4lld:pubmed
pubmed-article:18328118pubmed:dateCreated2008-4-23lld:pubmed
pubmed-article:18328118pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18328118pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18328118pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18328118pubmed:abstractTextAnemia of chronic kidney disease (CKD) decreases patients' health-related quality of life (HRQoL). The objective of this subanalysis was to determine the effect of every-other-week (Q2W) darbepoetin alfa on hemoglobin (Hb) levels and HRQoL measures in subjects with CKD who are naïve to erythropoiesis-stimulating agents (ESAs).lld:pubmed
pubmed-article:18328118pubmed:languageenglld:pubmed
pubmed-article:18328118pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18328118pubmed:citationSubsetIMlld:pubmed
pubmed-article:18328118pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18328118pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18328118pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18328118pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18328118pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18328118pubmed:statusMEDLINElld:pubmed
pubmed-article:18328118pubmed:monthAprlld:pubmed
pubmed-article:18328118pubmed:issn1473-4877lld:pubmed
pubmed-article:18328118pubmed:authorpubmed-author:CharytanChaim...lld:pubmed
pubmed-article:18328118pubmed:authorpubmed-author:Abu-AlfaAli...lld:pubmed
pubmed-article:18328118pubmed:authorpubmed-author:GlobeDeniseDlld:pubmed
pubmed-article:18328118pubmed:authorpubmed-author:ScarlataDebra...lld:pubmed
pubmed-article:18328118pubmed:authorpubmed-author:AudhyaPaulPlld:pubmed
pubmed-article:18328118pubmed:authorpubmed-author:SloanLanceLlld:pubmed
pubmed-article:18328118pubmed:authorpubmed-author:SekkarieMoham...lld:pubmed
pubmed-article:18328118pubmed:issnTypeElectroniclld:pubmed
pubmed-article:18328118pubmed:volume24lld:pubmed
pubmed-article:18328118pubmed:ownerNLMlld:pubmed
pubmed-article:18328118pubmed:authorsCompleteYlld:pubmed
pubmed-article:18328118pubmed:pagination1091-100lld:pubmed
pubmed-article:18328118pubmed:meshHeadingpubmed-meshheading:18328118...lld:pubmed
pubmed-article:18328118pubmed:meshHeadingpubmed-meshheading:18328118...lld:pubmed
pubmed-article:18328118pubmed:meshHeadingpubmed-meshheading:18328118...lld:pubmed
pubmed-article:18328118pubmed:meshHeadingpubmed-meshheading:18328118...lld:pubmed
pubmed-article:18328118pubmed:meshHeadingpubmed-meshheading:18328118...lld:pubmed
pubmed-article:18328118pubmed:meshHeadingpubmed-meshheading:18328118...lld:pubmed
pubmed-article:18328118pubmed:meshHeadingpubmed-meshheading:18328118...lld:pubmed
pubmed-article:18328118pubmed:meshHeadingpubmed-meshheading:18328118...lld:pubmed
pubmed-article:18328118pubmed:meshHeadingpubmed-meshheading:18328118...lld:pubmed
pubmed-article:18328118pubmed:meshHeadingpubmed-meshheading:18328118...lld:pubmed
pubmed-article:18328118pubmed:meshHeadingpubmed-meshheading:18328118...lld:pubmed
pubmed-article:18328118pubmed:meshHeadingpubmed-meshheading:18328118...lld:pubmed
pubmed-article:18328118pubmed:meshHeadingpubmed-meshheading:18328118...lld:pubmed
pubmed-article:18328118pubmed:year2008lld:pubmed
pubmed-article:18328118pubmed:articleTitleThe association of darbepoetin alfa with hemoglobin and health-related quality of life in patients with chronic kidney disease not receiving dialysis.lld:pubmed
pubmed-article:18328118pubmed:affiliationYale School of Medicine, New Haven, CT 06520-8029, USA. ali.abu-alfa@yale.edu <ali.abu-alfa@yale.edu>lld:pubmed
pubmed-article:18328118pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18328118pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:18328118pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:18328118pubmed:publicationTypeMulticenter Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18328118lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18328118lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18328118lld:pubmed